Lars Lykke THOMSEN,Tobias S. CHRISTENSEN,Hans ANDREASEN
申请号：
US15554762
公开号：
US20180042960A1
申请日:
2016.03.17
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of Restless Leg Syndrome (RLS) of a human patient, wherein the human patient prior to treatment has a magnetic resonance phase imaging of 0.02 radians above the average value of a control group in the substantia nigra, thalamus, putamen, orpallidum. The invention provides a higher probability for a RLS patient being treated to experience a relief in symptoms.
